Nu Skin Enterprises Statistics
Total Valuation
NUS has a market cap or net worth of $531.44 million. The enterprise value is $867.62 million.
| Market Cap | 531.44M |
| Enterprise Value | 867.62M |
Important Dates
The next confirmed earnings date is Thursday, August 8, 2024, after market close.
| Earnings Date | Aug 8, 2024 |
| Ex-Dividend Date | May 31, 2024 |
Share Statistics
NUS has 49.67 million shares outstanding. The number of shares has decreased by -1.04% in one year.
| Shares Outstanding | 49.67M |
| Shares Change (YoY) | -1.04% |
| Shares Change (QoQ) | +0.37% |
| Owned by Insiders (%) | 2.18% |
| Owned by Institutions (%) | 82.31% |
| Float | 48.66M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 8.49 |
| PS Ratio | 0.28 |
| Forward PS | 0.29 |
| PB Ratio | 0.66 |
| P/FCF Ratio | 6.27 |
| PEG Ratio | 2.35 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.91, with an EV/FCF ratio of 10.24.
| EV / Earnings | n/a |
| EV / Sales | 0.46 |
| EV / EBITDA | 6.91 |
| EV / EBIT | 42.50 |
| EV / FCF | 10.24 |
Financial Position
The company has a current ratio of 2.09, with a Debt / Equity ratio of 0.69.
| Current Ratio | 2.09 |
| Quick Ratio | 0.93 |
| Debt / Equity | 0.69 |
| Debt / EBITDA | 4.44 |
| Debt / FCF | 6.58 |
| Interest Coverage | 2.79 |
Financial Efficiency
Return on equity (ROE) is -0.40% and return on invested capital (ROIC) is -0.76%.
| Return on Equity (ROE) | -0.40% |
| Return on Assets (ROA) | -0.20% |
| Return on Capital (ROIC) | -0.76% |
| Revenue Per Employee | $514,858 |
| Profits Per Employee | -$896 |
| Employee Count | 3,700 |
| Asset Turnover | 1.05 |
| Inventory Turnover | 1.90 |
Taxes
In the past 12 months, NUS has paid $16.41 million in taxes.
| Income Tax | 16.41M |
| Effective Tax Rate | 125.32% |
Stock Price Statistics
The stock price has decreased by -68.10% in the last 52 weeks. The beta is 1.16, so NUS's price volatility has been higher than the market average.
| Beta (5Y) | 1.16 |
| 52-Week Price Change | -68.10% |
| 50-Day Moving Average | 12.61 |
| 200-Day Moving Average | 15.93 |
| Relative Strength Index (RSI) | 29.85 |
| Average Volume (20 Days) | 1,054,232 |
Short Selling Information
The latest short interest is 2.21 million, so 4.44% of the outstanding shares have been sold short.
| Short Interest | 2.21M |
| Short Previous Month | 1.63M |
| Short % of Shares Out | 4.44% |
| Short % of Float | 4.54% |
| Short Ratio (days to cover) | 3.75 |
Income Statement
In the last 12 months, NUS had revenue of $1.90 billion and -$3.31 million in losses. Loss per share was -$0.07.
| Revenue | 1.90B |
| Gross Profit | 1.30B |
| Operating Income | 41.03M |
| Pretax Income | 13.09M |
| Net Income | -3.31M |
| EBITDA | 125.54M |
| EBIT | 20.42M |
| Loss Per Share | -$0.07 |
Balance Sheet
The company has $221.21 million in cash and $557.38 million in debt, giving a net cash position of -$336.18 million or -$6.77 per share.
| Cash & Cash Equivalents | 221.21M |
| Total Debt | 557.38M |
| Net Cash | -336.18M |
| Net Cash Per Share | -$6.77 |
| Equity (Book Value) | 810.21M |
| Book Value Per Share | 16.31 |
| Working Capital | 337.96M |
Cash Flow
In the last 12 months, operating cash flow was $144.03 million and capital expenditures -$59.28 million, giving a free cash flow of $84.75 million.
| Operating Cash Flow | 144.03M |
| Capital Expenditures | -59.28M |
| Free Cash Flow | 84.75M |
| FCF Per Share | $1.71 |
Margins
Gross margin is 68.42%, with operating and profit margins of 2.15% and -0.17%.
| Gross Margin | 68.42% |
| Operating Margin | 2.15% |
| Pretax Margin | 0.69% |
| Profit Margin | -0.17% |
| EBITDA Margin | 6.59% |
| EBIT Margin | 1.07% |
| FCF Margin | 4.45% |
Dividends & Yields
This stock pays an annual dividend of $0.24, which amounts to a dividend yield of 2.24%.
| Dividend Per Share | $0.24 |
| Dividend Yield | 2.24% |
| Dividend Growth (YoY) | -41.94% |
| Years of Dividend Growth | 23 |
| Payout Ratio | n/a |
| Buyback Yield | 1.04% |
| Shareholder Yield | 3.28% |
| Earnings Yield | -0.62% |
| FCF Yield | 15.95% |
Analyst Forecast
The average price target for NUS is $20.83, which is 94.67% higher than the current price. The consensus rating is "Hold".
| Price Target | $20.83 |
| Price Target Difference | 94.67% |
| Analyst Consensus | Hold |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
NUS has an Altman Z-Score of 3.21 and a Piotroski F-Score of 4.
| Altman Z-Score | 3.21 |
| Piotroski F-Score | 4 |